Antimicrobial Resistance

Antimicrobial resistance (AMR) is an ongoing global public health crisis, as evidenced by approximately five million deaths in 2019 and predicted deaths of approximately ten million annually by 2050. According to the World Health Organization, AMR has significant financial implications and The World Bank has estimated that AMR could result in US$ 1 trillion additional healthcare costs by 2050, and US$ 1 trillion to US$ 3.4 trillion gross domestic product (GDP) losses per year by 2030.

AMR is a concern within healthcare, not only in bacteria but also fungi, parasites and viruses, both in the community and healthcare settings. A coordinated and integrated One Health approach is required to tackle the issue impacting human health from human, animal, agriculture and environmental sectors. To address the AMR pandemic, regulatory and policy frameworks have been prepared at local, national and international levels with multi-faceted proposals and advances encompassing surveillance, diagnostics, infection prevention, antibiotic prescribing and variation of existing and novel treatment approaches. Furthermore, scientists continue to focus research on the development of novel antimicrobials, the repurposing of drugs, novel therapeutic approaches and the development of vaccines.

In this Special Issue of the British Journal of Biomedical Science (Impact Factor of 4.6 and Citescore of 5.8) we invite high quality articles that investigate a range of aspects relating to addressing AMR within the human healthcare sector, to include but not limited to:

• Policy development
• One health initiatives
• The relevance and impact of antimicrobial usage and AMR organisms in the environmental, agricultural and veterinary sectors
• Surveillance of AMR at national, international and global levels
• Emerging AMR in human infection
• Improvements in laboratory diagnostics and clinical diagnosis
• Novel drug development, repurposing and novel therapeutic approaches.
• Implications for infection prevention
• Developments in vaccinology
• Antimicrobial stewardship
• Education and communication strategies to help inform stakeholders and service users
• Approaches to embedding AMR education into the biomedical science curriculum

As with all scientific research, authors are required to ensure that their research, whether it be original research, review article or case study, is supported by a robust evidence-base for consideration for publication.

Any questions? Please email the Publishing Office.

IBMS Members
IBMS members can benefit from a full waiver of the APC and should email the Publishing Office with their IBMS membership reference number prior to submission of the manuscript to confirm their waiver.

Article types and fees

This Special Issue accepts the following article types, unless otherwise specified in the Special Issue description:

• Biomedical Science in Brief
• Case Report
• Editorial
• Letter to the Editor
• Original Research
• Review

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Special Issue accepts the following article types, unless otherwise specified in the Special Issue description:

• Biomedical Science in Brief
• Case Report
• Editorial
• Letter to the Editor
• Original Research
• Review

Keywords: Antimicrobial resistance, AMR, fungi, parasites, viruses, One Health